Stocks and Investing Stocks and Investing
Tue, September 19, 2017
Mon, September 18, 2017
Fri, September 15, 2017
Thu, September 14, 2017
Wed, September 13, 2017
Tue, September 12, 2017
Mon, September 11, 2017
Fri, September 8, 2017
Thu, September 7, 2017
Wed, September 6, 2017

Vamil Divan Maintained (TEVA) at Sell with Increased Target to $14 on, Sep 6th, 2017


Published on 2024-10-25 22:38:45 - WOPRAI, Vamil Divan
  Print publication without navigation


Vamil Divan of JMP Securities, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Sell with Increased Target from $13 to $14 on, Sep 6th, 2017.

Vamil has made no other calls on TEVA in the last 4 months.



There are 9 other peers that have a rating on TEVA. Out of the 9 peers that are also analyzing TEVA, 7 agree with Vamil's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Liav Abraham of "Citigroup" Downgraded from Strong Buy to Hold on, Wednesday, August 16th, 2017
  • Douglas Tsao of "Barclays" Maintained at Hold with Decreased Target to $23 on, Monday, August 7th, 2017
  • Tyler Van Buren of "Cowen & Co." Downgraded from Buy to Hold on, Friday, August 4th, 2017
  • Aaron Gal of "Bernstein" Downgraded from Buy to Hold on, Friday, August 4th, 2017
  • Derek Archila of "Oppenheimer" Downgraded from Buy to Hold on, Thursday, August 3rd, 2017
  • Irina Rivkind Koffler of "Mizuho" Upgraded from Sell to Hold on, Friday, June 16th, 2017
  • Louise Chen of "Cantor Fitzgerald" Initiated at Hold and Held Target at $31 on, Thursday, June 15th, 2017


These are the ratings of the 2 analyists that currently disagree with Vamil


  • David Risinger of "Morgan Stanley" Downgraded from Hold to Sell and Held Target at $16 on, Monday, August 7th, 2017
  • Randall Stanicky of "RBC Capital" Downgraded from Buy to Sell on, Friday, August 4th, 2017